Acrivon Therapeutics is halting work on developing its lead drug for ovarian and bladder cancers, instead focusing the Eli ...
UK researchers have begun an early stage clinical trial on AstraZeneca's experimental drug from the new WEE1 kinase drug class in head and neck cancer. The Combinations Alliance – a joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback